A detailed history of Hrt Financial LP transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 10,961 shares of KZR stock, worth $71,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,961
Previous 77,736 85.9%
Holding current value
$71,465
Previous $46,000 82.61%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.53 - $0.77 $35,390 - $51,416
-66,775 Reduced 85.9%
10,961 $8,000
Q2 2024

Aug 12, 2024

BUY
$0.6 - $0.92 $46,641 - $71,517
77,736 New
77,736 $46,000
Q4 2023

Feb 09, 2024

BUY
$0.72 - $1.15 $74,725 - $119,352
103,785 New
103,785 $98,000
Q1 2023

May 12, 2023

BUY
$3.13 - $7.31 $81,214 - $189,672
25,947 New
25,947 $81,000
Q2 2022

Aug 12, 2022

BUY
$4.58 - $17.13 $44,059 - $164,790
9,620 Added 42.14%
32,449 $268,000
Q1 2022

May 16, 2022

BUY
$12.3 - $18.33 $280,796 - $418,455
22,829 New
22,829 $379,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.